Letter: Dual Antithrombotic Therapy Following Iliac Vein Stenting: Important Findings but Persistent Uncertainties

Abstract

Get full access to this article

View all access options for this article.

References

Qian

Shi

Hao

, et al. One-year outcomes of dual versus single antithrombotic therapy following iliac vein stenting for acute iliofemoral DVT. Angiology. Published online March 26, 2026. doi:10.1177/00033197261430778

Qiu

Huang

Wang

, et al. Anticoagulation plus antiplatelet therapy versus anticoagulation alone following iliac vein stent implantation in acute and subacute deep vein thrombosis: a multicenter study with propensity score matching. Thromb Res. 2024;244:109197.

Piazza

Goldhaber

SZ.

Venous thromboembolism and atherothrombosis: an integrated approach. Circulation. 2010;121(19):2146-2150.

Mackman

New insights into the mechanisms of venous thrombosis. J Clin Invest. 2012;122(7):2331-2336.

Saleem

Raju

An overview of in-stent restenosis in iliofemoral venous stents. J Vasc Surg Venous Lymphat Disord. 2022;10(2):492-503.e2.

Kahn

Comerota

Cushman

, et al. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2014;130(18):1636-1661.

Vedantham

Goldhaber

Julian

, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med. 2017;377(23):2240-2252.

Twine

Kakkos

Aboyans

, et al. Editor’s Choice – European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases. Eur J Vasc Endovasc Surg. 2023;65(5):627-689.

Guo

Chen

, et al. Principles of Optimal Antithrombotic Therapy for Iliac VEnous Stenting (POATIVES): a national expert-based Delphi consensus study. J Vasc Surg Venous Lymphat Disord. 2024;12(2):101739.